Charcot Arthropathy Treatment
40 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which bisphosphonate treatment was administered as a single dose infusion?

  • Calcitonin
  • Zolendronate
  • Pamidronate (correct)
  • Alendronate
  • What was the duration of the alendronate intervention in the study?

  • 1 month
  • 6 months (correct)
  • 12 months
  • 4 weeks
  • How many subjects were involved in the study of zolendronate?

  • 32
  • 50
  • 20
  • 39 (correct)
  • What was the route of administration for salmon calcitonin in the study?

    <p>Nasal spray plus oral</p> Signup and view all the answers

    Which treatment showed a significant reduction in bone turnover compared to controls?

    <p>Alendronate</p> Signup and view all the answers

    What was the sample size of the alendronate study?

    <p>20</p> Signup and view all the answers

    Which intervention involved a daily administration approach over a period of 6 months?

    <p>Calcitonin</p> Signup and view all the answers

    Which therapy was characterized by a randomised controlled trial design?

    <p>All of the above</p> Signup and view all the answers

    What is generally accepted as the gold standard therapy for Charcot arthropathy?

    <p>Non-removable casting</p> Signup and view all the answers

    What was the first choice of management for Charcot arthropathy in the United States?

    <p>Total contact casting</p> Signup and view all the answers

    What should patients be instructed to monitor during the rehabilitation phase?

    <p>Swelling, redness, and warmth of the foot</p> Signup and view all the answers

    After what condition should the Charcot restraint orthotic walker (CROW) be used in patients?

    <p>After swelling is controlled</p> Signup and view all the answers

    What is the rehabilitation duration suggested before gradually transitioning to footwear?

    <p>8–17 months</p> Signup and view all the answers

    Which of the following casts is typically used for the majority of time during patient rehabilitation?

    <p>Removable bivalve cast</p> Signup and view all the answers

    What percentage of cases in the UK utilized non-removable casts at any one point of time?

    <p>34%</p> Signup and view all the answers

    What type of imaging follow-up was used to correlate with clinical findings during the study?

    <p>MRI</p> Signup and view all the answers

    What was found to be significantly longer for patients treated with zolendronic acid compared to the placebo group?

    <p>Time to clinical resolution</p> Signup and view all the answers

    What mechanism is associated with the pathogenesis of acute Charcot arthropathy?

    <p>Increased osteoclastic activity and uncontrolled inflammation</p> Signup and view all the answers

    What recent advancement has contributed to understanding the mechanisms of osteoclastic activity in Charcot arthropathy?

    <p>The identification of RANKL as a key factor</p> Signup and view all the answers

    What was reported about the use of bisphosphonates in the treatment of acute Charcot arthropathy?

    <p>Recent reviews indicate weak evidence for their use</p> Signup and view all the answers

    What is the current status of the study involving recombinant human parathyroid hormone for acute Charcot arthropathy?

    <p>In progress with no reported outcomes</p> Signup and view all the answers

    What do some authors consider bisphosphonates in relation to standard management for acute Charcot arthropathy?

    <p>Useful adjuncts</p> Signup and view all the answers

    In what context is the receptor activator of nuclear factor κβ ligand (RANKL) mentioned?

    <p>As a key factor for osteoclast differentiation</p> Signup and view all the answers

    What does recent data indicate about the median time to resolution for patients receiving bisphosphonates?

    <p>It is greater compared to individuals who did not receive them</p> Signup and view all the answers

    What is a potential limitation of using in vitro techniques for generating antiresorptive therapies?

    <p>There is no definite benefit for patients with extensive fractures.</p> Signup and view all the answers

    How do osteoclasts from patients with acute Charcot arthropathy respond to RANKL compared to those from diabetic patients?

    <p>They exhibit an increased response to RANKL.</p> Signup and view all the answers

    What role does TNF-α play in the context of Charcot arthropathy?

    <p>It regulates the inflammatory response.</p> Signup and view all the answers

    What was one outcome of the pilot study on the effect of human parathyroid hormone on patients with Charcot osteoarthropathy?

    <p>It indicated faster edema control and temperature stabilization.</p> Signup and view all the answers

    What is the significance of the increased expression of TNF-α in activated monocytes in Charcot arthropathy patients?

    <p>It correlates with an increased immune response.</p> Signup and view all the answers

    Why are larger studies recommended despite the pilot observations of anabolic agents on Charcot arthropathy?

    <p>Pilot studies have limited sample sizes affecting reliability.</p> Signup and view all the answers

    What is one hypothesis related to proinflammatory cytokines in Charcot arthropathy?

    <p>They play a crucial role in inflammatory osteolysis.</p> Signup and view all the answers

    What does the observed increase in serum levels of TNF-α in active Charcot arthropathy suggest?

    <p>Increased inflammatory activity.</p> Signup and view all the answers

    What is the main focus of the observed interactions mentioned?

    <p>The relationship between inflammation and bone resorption</p> Signup and view all the answers

    Which therapy remains the primary medical treatment for acute Charcot arthropathy?

    <p>Offloading and casting therapy</p> Signup and view all the answers

    What remains unclear about the antiresorptive therapies mentioned?

    <p>Their overall benefit on healing</p> Signup and view all the answers

    What new pharmacological targets may provide therapy improvements according to the observations?

    <p>RANKL and TNF-α mediated osteoclastic activity</p> Signup and view all the answers

    What aspect of anabolic therapy is yet to be established?

    <p>Benefits of parathyroid hormone therapy</p> Signup and view all the answers

    What does the research imply regarding removable devices compared to non-removable casts?

    <p>Non-removable casts show superior outcomes</p> Signup and view all the answers

    Which of the following conditions is monitored using infrared thermometry?

    <p>Healing of acute Charcot’s arthropathy</p> Signup and view all the answers

    What emerging field may lead to improvements in therapies for bone conditions?

    <p>Cellular biology</p> Signup and view all the answers

    Study Notes

    Charcot Arthropathy Treatment

    • Casting therapy remains the main treatment for acute Charcot arthropathy.
    • Non-removable casts are generally considered the gold standard for Charcot arthropathy.
    • In a US audit, total-contact casting was the initial management choice in only 49% of cases.
    • In a UK audit, non-removable casts were used at any one point in only 34% of cases.
    • Patients should be carefully rehabilitated after casting, starting with short steps in new footwear.
    • Removable bivalve casts or cast walkers should be worn for the majority of time during rehabilitation.
    • For patients with hindfoot involvement, a Charcot restraint orthotic walker (CROW) can be used instead of a removable cast.
    • The CROW is a bespoke bivalved total-contact device that externally fixates the ankle and cushions the vulnerable medial malleolar area.
    • Patients should be instructed to monitor their feet for swelling, redness, and warmth during rehabilitation.
    • Patients should seek urgent advice if they experience any increase in warmth, swelling, or redness.

    Antiresorptive Therapies

    • Antiresorptive therapies, such as bisphosphonates, are used to treat acute Charcot arthropathy.
    • The use of bisphosphonates in Charcot arthropathy is not currently approved by the Food and Drug Administration (FDA) in the United States.
    • Evidence to support the use of bisphosphonates in Charcot arthropathy is weak.
    • The window of opportunity to administer bisphosphonates may be limited, as there may be no benefit for patients with extensive fractures and bone fragmentation at presentation.
    • Studies have shown mixed results on the effectiveness of bisphosphonates in reducing bone turnover and symptoms.
    • Bisphosphonates have not been shown to improve fracture healing or resolution of arthropathy.
    • Zolendronic acid has been shown to require significantly longer immobilization time compared to placebo.
    • An anabolic agent, such as parathyroid hormone, may speed up clinical resolution and fracture healing.
    • A pilot study has shown that human parathyroid hormone may improve fracture consolidation, oedema control, temperature stabilization, and return to weight bearing.

    Future Therapies

    • Cellular biology studies have helped identify the receptor activator of nuclear factor κβ ligand (RANKL) as a key factor in osteoclast differentiation and regulation.
    • Osteoclasts from patients with acute Charcot arthropathy exhibit an increased response to RANKL compared to osteoclasts from diabetic patients and healthy subjects.
    • Proinflammatory cytokines, such as TNF-α, are thought to play a role in the inflammatory osteolysis of Charcot arthropathy.
    • Patients with active Charcot arthropathy have increased expression of TNF-α by activated monocytes and increased serum levels of TNF-α compared with diabetic control patients.
    • Targeting RANKL or TNF-α in future therapies may help inhibit osteoclastic activity and improve the management of Charcot arthropathy.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    This quiz focuses on the treatment options for Charcot arthropathy, including casting techniques and rehabilitation strategies. Learn about the effectiveness of non-removable casts and the use of Charcot restraint orthotic walkers. Test your knowledge on proper patient management after casting.

    More Like This

    Use Quizgecko on...
    Browser
    Browser